DMT-dT-CE-Phosphoramidite
DMT-dT-CE-Phosphoramidite - N (Normal) / 0.25g / 30mL screwed bottle-28 is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Related Products
Details
Details
DMT-dT-CE-Phosphoramidite is a standard DNA phosphoramidite monomer used for solid-phase oligonucleotide synthesis[1][2]. It contains a 5’-dimethoxytrityl (DMT) protecting group for 5’-hydroxyl protection, a cyanoethyl (CE) protecting group on phosphite, and a thymine.
This phosphoramidite enables the incorporation of deoxythymidine (dT) residues into synthetic DNA-containing oligonucleotides with high coupling efficiency and sequence fidelity.
Applications
Therapeutic Oligonucleotide
As a core component for DNA-based aptamers, antisense oligonucleotides, or hybrid oligonucleotides (e.g., DNA–RNA chimeras).
Hybridization probes
Used to generate DNA probes for microarrays, in situ hybridization, or diagnostic assays.
Molecular biology tools
For assembling standard or modified DNA sequences used in PCR, qPCR, cloning, sequencing primers, CRISPR guide templates, and NGS barcodes.
Features and Benefits
High Coupling Efficiency
High coupling efficiency and reproducibility in solid-phase DNA synthesis
Wide Compatibility
Compatible with standard phosphoramidite chemistry and most commercial DNA synthesizers
Excellent Purity
Produces oligonucleotides with excellent purity and predictable deprotection behavior
Flexible Scale
Suitable for both research-scale and GMP-grade oligonucleotide production
Security Information
- Storage: Store in a dry, inert atmosphere at -20 °C.
- Recommended deprotection: 8 h at 55 °C in concentrated ammonia, or 10 min at 65 °C in AMA (ammonia/methylamine, 1:1 v/v).
- Compatibility: Can be used alongside modified phosphoramidites (e.g., 2′-OMe, 2′-MOE, LNA) to synthesize chimeric oligonucleotides.
Reference
[1] Beaucage, S. L., and Marvin H. Caruthers. "Deoxynucleoside phosphoramidites—a new class of key intermediates for deoxypolynucleotide synthesis." Tetrahedron letters 22, no. 20 (1981): 1859-1862.
[2] Caruthers, M. H., A. D. Barone, S. L. Beaucage, D. R. Dodds, E. F. Fisher, L. J. McBride, M. Matteucci, Z. Stabinsky, and J-Y. Tang. "[15] Chemical synthesis of deoxyoligonucleotides by the phosphoramidite method." In Methods in enzymology, vol. 154, pp. 287-313. Academi c Press, 1987.
Specifications
Specifications
-
Catalog No.PD4-002PD4-002PD4-002PD4-002PD4-002PD4-002PD4-002PD4-002
-
CAS No.98796-51-198796-51-198796-51-198796-51-198796-51-198796-51-198796-51-198796-51-1
-
SMILESO=C1C(C)=CN([C@H]2C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C3=CC=C(OC)C=C3)(C4=CC=CC=C4)C5=CC=C(OC)C=C5)O2)C(N1)=OO=C1C(C)=CN([C@H]2C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C3=CC=C(OC)C=C3)(C4=CC=CC=C4)C5=CC=C(OC)C=C5)O2)C(N1)=OO=C1C(C)=CN([C@H]2C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C3=CC=C(OC)C=C3)(C4=CC=CC=C4)C5=CC=C(OC)C=C5)O2)C(N1)=OO=C1C(C)=CN([C@H]2C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C3=CC=C(OC)C=C3)(C4=CC=CC=C4)C5=CC=C(OC)C=C5)O2)C(N1)=OO=C1C(C)=CN([C@H]2C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C3=CC=C(OC)C=C3)(C4=CC=CC=C4)C5=CC=C(OC)C=C5)O2)C(N1)=OO=C1C(C)=CN([C@H]2C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C3=CC=C(OC)C=C3)(C4=CC=CC=C4)C5=CC=C(OC)C=C5)O2)C(N1)=OO=C1C(C)=CN([C@H]2C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C3=CC=C(OC)C=C3)(C4=CC=CC=C4)C5=CC=C(OC)C=C5)O2)C(N1)=OO=C1C(C)=CN([C@H]2C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C3=CC=C(OC)C=C3)(C4=CC=CC=C4)C5=CC=C(OC)C=C5)O2)C(N1)=O
-
Molecular FormulaC40H49N4O8PC40H49N4O8PC40H49N4O8PC40H49N4O8PC40H49N4O8PC40H49N4O8PC40H49N4O8PC40H49N4O8P
-
Molecular Weight744.81744.81744.81744.81744.81744.81744.81744.81
-
AppearanceWhite to off-white powderWhite to off-white powderWhite to off-white powderWhite to off-white powderWhite to off-white powderWhite to off-white powderWhite to off-white powderWhite to off-white powder
-
PurityHPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%
-
Storage Condition-20℃-20℃-20℃-20℃-20℃-20℃-20℃-20℃
-
Moisture ContentK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/w
Documentation
Documentation
DMT-dT-CE-Phosphoramidite is a standard DNA phosphoramidite monomer used for solid-phase oligonucleotide synthesis[1][2]. It contains a 5’-dimethoxytrityl (DMT) protecting group for 5’-hydroxyl protection, a cyanoethyl (CE) protecting group on phosphite, and a thymine.
This phosphoramidite enables the incorporation of deoxythymidine (dT) residues into synthetic DNA-containing oligonucleotides with high coupling efficiency and sequence fidelity.
Applications
Therapeutic Oligonucleotide
As a core component for DNA-based aptamers, antisense oligonucleotides, or hybrid oligonucleotides (e.g., DNA–RNA chimeras).
Hybridization probes
Used to generate DNA probes for microarrays, in situ hybridization, or diagnostic assays.
Molecular biology tools
For assembling standard or modified DNA sequences used in PCR, qPCR, cloning, sequencing primers, CRISPR guide templates, and NGS barcodes.
Features and Benefits
High Coupling Efficiency
High coupling efficiency and reproducibility in solid-phase DNA synthesis
Wide Compatibility
Compatible with standard phosphoramidite chemistry and most commercial DNA synthesizers
Excellent Purity
Produces oligonucleotides with excellent purity and predictable deprotection behavior
Flexible Scale
Suitable for both research-scale and GMP-grade oligonucleotide production
Security Information
- Storage: Store in a dry, inert atmosphere at -20 °C.
- Recommended deprotection: 8 h at 55 °C in concentrated ammonia, or 10 min at 65 °C in AMA (ammonia/methylamine, 1:1 v/v).
- Compatibility: Can be used alongside modified phosphoramidites (e.g., 2′-OMe, 2′-MOE, LNA) to synthesize chimeric oligonucleotides.
Reference
[1] Beaucage, S. L., and Marvin H. Caruthers. "Deoxynucleoside phosphoramidites—a new class of key intermediates for deoxypolynucleotide synthesis." Tetrahedron letters 22, no. 20 (1981): 1859-1862.
[2] Caruthers, M. H., A. D. Barone, S. L. Beaucage, D. R. Dodds, E. F. Fisher, L. J. McBride, M. Matteucci, Z. Stabinsky, and J-Y. Tang. "[15] Chemical synthesis of deoxyoligonucleotides by the phosphoramidite method." In Methods in enzymology, vol. 154, pp. 287-313. Academi c Press, 1987.
-
Catalog No.PD4-002PD4-002PD4-002PD4-002PD4-002PD4-002PD4-002PD4-002
-
CAS No.98796-51-198796-51-198796-51-198796-51-198796-51-198796-51-198796-51-198796-51-1
-
SMILESO=C1C(C)=CN([C@H]2C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C3=CC=C(OC)C=C3)(C4=CC=CC=C4)C5=CC=C(OC)C=C5)O2)C(N1)=OO=C1C(C)=CN([C@H]2C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C3=CC=C(OC)C=C3)(C4=CC=CC=C4)C5=CC=C(OC)C=C5)O2)C(N1)=OO=C1C(C)=CN([C@H]2C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C3=CC=C(OC)C=C3)(C4=CC=CC=C4)C5=CC=C(OC)C=C5)O2)C(N1)=OO=C1C(C)=CN([C@H]2C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C3=CC=C(OC)C=C3)(C4=CC=CC=C4)C5=CC=C(OC)C=C5)O2)C(N1)=OO=C1C(C)=CN([C@H]2C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C3=CC=C(OC)C=C3)(C4=CC=CC=C4)C5=CC=C(OC)C=C5)O2)C(N1)=OO=C1C(C)=CN([C@H]2C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C3=CC=C(OC)C=C3)(C4=CC=CC=C4)C5=CC=C(OC)C=C5)O2)C(N1)=OO=C1C(C)=CN([C@H]2C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C3=CC=C(OC)C=C3)(C4=CC=CC=C4)C5=CC=C(OC)C=C5)O2)C(N1)=OO=C1C(C)=CN([C@H]2C[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@H](COC(C3=CC=C(OC)C=C3)(C4=CC=CC=C4)C5=CC=C(OC)C=C5)O2)C(N1)=O
-
Molecular FormulaC40H49N4O8PC40H49N4O8PC40H49N4O8PC40H49N4O8PC40H49N4O8PC40H49N4O8PC40H49N4O8PC40H49N4O8P
-
Molecular Weight744.81744.81744.81744.81744.81744.81744.81744.81
-
AppearanceWhite to off-white powderWhite to off-white powderWhite to off-white powderWhite to off-white powderWhite to off-white powderWhite to off-white powderWhite to off-white powderWhite to off-white powder
-
PurityHPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%
-
Storage Condition-20℃-20℃-20℃-20℃-20℃-20℃-20℃-20℃
-
Moisture ContentK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/wK.F.≤0.20% w/w
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
